A B S T R A CT Five families with inherited thyroxinebinding globulin (TBG) abnormalities were studied. On the basis of serum thyroxine (T4)-binding capacity of TBG in affected males, three family types were identified: TBG deficiency, low TBG, and high TBG capacity. In all families evidence for X-linked inheritance was obtained and in one family all criteria establishing this mode of inheritance were met. Only females were heterozygous, exhibiting values intermediate between affected males and normals. Overlap in heterozygotes was most commonly encountered in families with low TBG.
INTRODUCTION
In 1959 Beierwaltes and Robbins described the first family with increased thyroxine-binding globulin
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(TBG)1 capacity (1). Subsequently, TBG abnormalities have been reported in 20 additional and apparently unrelated families: 15 with diminished (2-14) and 5 with excess (15) (16) (17) (18) (19) maximal capacity of thyroxine (T4) -binding to TBG. In 6 of the 15 families with diminished TBG capacity, males had no demonstrable Tt-binding to the TBG zone on electrophoresis, and with only a single exception (7) , affected females had approximately half normal binding capacity (2) (3) (4) (5) 7) . The ability to identify the heterozygous ("carrier") state has helped establish X-chromosome-linked inheritance patterns in these families. Of the remaining nine families with diminished TBG, in eight, affected males had low but detectable TBG capacity (8) (9) (10) (11) (12) (13) (14) , and in some instances "carrier" state in females could not be clearly identified because of overlap in their TBG capacity values with either affected males (8, 9) or normals (13) . Because of the presence of TBG in the hemizygous-affected subjects and inability to distinguish the heterozygous state with certainty, in three out of nine families, X-linked mode of inheritance was less obvious (8, 9, 12) . Similarly, only in four of the six families with increased T4-binding capacity of TBG was X-linked pattern of inheritance recognized (16) (17) (18) (19) , whereas, in two, an autosomal dominant transmission was suggested (15, 20) . On closer scrutiny, it appears that except for two families with unpublished pedigrees (6, 14) no instance of incompatibility with Xlinkage could be demonstrated.
During the past 3 years we studied five families with inherited TBG abnormalities: one with TBG deficiency2 (5), three with low TBG, and one with high TBG. This communication presents clinical data on four families not previously described. An attempt was also made to elucidate the nature of these defects using immunologic and biochemical techniques for the characterization of the "abnormal" TBG. From these and previous studies by others and ourselves, a unifying hypothesis is advanced suggesting that mutations of a single gene locus on the X-chromosome may be the mechanism for all types of TBG abnormalities in man so far described.
LABORATORY METHODS

Materials
Sephadex G-100 (medium) was obtained from Pharmacia Fine Chemicals, Inc., Piscataway, N. J. and prepared for column filtration by repeated washing with buffered saline (12.1 mm Na2HPO4, 1.28 mm KH2PO4, and 145.4 mM NaCl), pH 7.4. Pevikon C-870 (powdered copolymer of polyvinyl chloride and polyvinyl acetate) was obtained from Mercer Chemicals Corporation, New York, and prepared as previously described (21) . Agarose ( Radioisotopes. (a) L-Thyroxine-'I (T4-12'I), SA 40 to 90 tCi/tg depending on the lot, was obtained from Abbott Laboratories, North Chicago, Ill. On descending paper chromatography in tertiary-amyl alcohol hexane 2 M ammonia (22), T4--2AI content of lots used was at least 90% of the total 'I activity. The following isotopically labeled compounds were obtained from New England Nuclear, Boston, Mass.: (b) Cortisol-4-_4C (F-4C) SA 0.143 uCi/g (lot 302-267) ; (c) D-aldosterone-4-j4C (Aldo-14C) SA 55 mCi/mmole or 0.153 ,Ci/,ug (lot 467-072); and (d) Testosterone-14C (Test-'4C) SA 50.6 mCi/mmole or 0.75 ,uCi/,ug (lot 302-153). All radioisotopes were used without further purification, diluted in ethanol, and evaporated to dryness in polystyrene tubes before addition of serum as previously described (23) .
Methods
Electrophoretic techniques. Reverse flow paper electrophoresis was carried out by the Elzinga, Carr, and Beierwaltes modification (24) of the Robbins method (25) in glycine acetate buffer pH 8.6 (26) .
Agarose electrophoresis was carried out, according to the method of Laurell and Nilehn (27) on an apparatus of their design, using tris-maleate buffer pH 8.6 (28) as previously described (23) .
'From here on the term TBG deficiency is reserved for families presenting undetectable T4-binding to TBG in affected hemizygous subjects. Similarly low TBG indicates that hemizygous affected have low but detectable T4-binding to TBG. The term high TBG is self-explanatory.
Antigen-antibody crossed electrophoresis was performed as described by Laurell (29) except that on occasion initial agarose electrophoresis was carried out on a modified apparatus permitting greater separation (30) , and barbital buffer was substituted with tris-maleate buffer to permit T4-'I binding to thyroxine-binding prealbumin (TBPA) (28) . For radioautography, gels were rapidly dried in a current of warm air without prior, fixation of proteins or staining and exposed to Kodak No-screen X-ray film8 as previously described (23) . After radioautography, the proteins were fixed with aqueous methanol-acetic acid and stained with amido black.
Pevikon-block electrophoresis was carried out by the method described by Miller-Eberhard (21) .
Immunoelectrophoresis was performed using the method described by Scheidegger (31 (32) , and by radioimmunoassay (33) . The latter was performed by Dr. Richard P. Levy on coded samples. Partial purification of TBG. 20 ml of serum (TBG capacity 61 Atg T4/100 ml) from a healthy pregnant donor was enriched with a tracer T4-1"I (0.02 ,ug/100 ml serum) and subjected to Pevikon-block electrophoresis. Two fractions containing the peak T4-'I activity (67% of the total) were pooled, concentrated by ultrafiltration to a final volume of 0.5 ml, and applied to a Sephadex G-100 column.
Three fractions of the highest specific activity were divided in four equal volumes and kept frozen at -20°C until used for immunization.
Antibody preparation. Two adult male New Zealand albino rabbits were immunized with 0.35 ml of the above described material emulsified in 0.7 ml of complete Freund's adjuvant. Injections were given subcutaneously in multiple sites at 2 wk interval. Blood was collected before immunization and at weekly intervals for a month after the last immunization.
Detection and titration of rabbit anti-human TBG antibodies. The presence of antibody to TBG was determined by the capacity of rabbit antiserum to TBG to clear the T4-'I activity of human serum located in the inter-a-globulin zone, on both paper and agarose electrophoreses. For this purpose, normal serum (TBG capacity of 20 ,tg T4/ 100 ml) was enriched with T4-'I and incubated with rabbit serum for 24-48 hr at 4°C. Uncentrifuged portions were then subjected to electrophoresis and the distribution of the radioisotope examined both qualitatively by radioautography (23) and quantitatively by strip counting (5) . Nonimmune rabbit serum obtained from the same animal before immunization was used as control.
Antibody titer was determined from the highest antiserum dilution capable of displacing the T4-2I activity associated with human TBG to the vy-globulin zone on paper and 8Eastman Kodak Co., Rochester, N. Y.
Inherited Thyroxine-Binding Globulin Abnormalities in Man agarose electrophoreses. Alternatively quantitative adsorption of the antibody using different amounts of TBG-containing unlabeled human serum was used. The specificity of a single antiserum possessing the highest antibody titer was examined by immunoelectrophoresis and by the Ouchterlony technique.
Routine tests of thyroid function. Total thyroxine content in serum was estimated from the protein-bound iodine (PBI)' concentration or determined by the competitivebinding assay (TTi) (34) , and the free T4 (FTa) calculated from the product of the TT4 and dialyzable fraction (DF) obtained by a modification (35) of the method of Oppenheimer, Squef, Surks, and Hauer (36) . Resin sponge triiodothyronine uptake (R-Ts) was determined using the Triosorb-kit,5 and serum total protein (TP) by refractometry.6 The FT4 index was obtained from the product of the PBI and R-Ts expressed as fraction of a normal control (37) , and the TBG index from the ratio of the R-Ts expressed as per cent of the normal control, and the PBI (2) . When the PBI was unavailable the TT4 was used for the estimation of these indexes (38) .
CLINICAL MATERIAL
Serum was obtained from members of the following families:
Family P. This family was brought to our attention because the proposita (Mi. P.) was shorter than her peers, had primary amenorrhea, and a PBI of 2.2 ig/100 ml which failed to rise with the daily administration of 120 mg of USP thyroid. Further investigation revealed that this patient had Turner's syndrome (XO) and TBG deficiency. There was no known family history of consanguinity, thyroid disease, or other congenital disorders. Both parents were Americans of Irish-Italian extraction. Detailed results from genetic studies of this family, demonstrating unequivocal proof for X-linked inherited TBG deficiency have been published (5 Fig. 1 Results of thyroid function tests are listed in Table II . Family L. The propositus (A. L.) was 17 yr old in June 1966, when he was referred for evaluation of delayed physical and sexual maturation. He was the product of an uneventful pregnancy and delivery. Early childhood development was normal. Because the parents were under the impression that there was a slowing in his growth. four determinations of PBI, cholesterol, and FT4 were obtained between April 1964 and June 1965. They ranged from 3.0 to 3.6 jg/100 ml, 140 to 180 mg/100 ml, and 1.4 to 1.7 ng/100 ml7 respectively. The 24 hr thyroidal 'I uptake was 24%. During the last year, before hospitalization, the appearance of pubic and axillary hair was noted as well as increased hair growth over legs and arms. On physical examination the patient was moderately obese weighing 166 lb. and appeared about 3 yr younger than his chronological age. Height was 66 inches. Teeth were normally erupted. He had minimal facial and axillary hair but more abundant pubic hair. There was no breast enlargement. Penis and testes were normal.
Karyotypic analysis of lymphocytes revealed 44 autosomes and XY sex chromosomal pattern. Thyroidal 'I uptake was 20, 23, and 24% at 4, 6, and 24 hr, which after a single intramuscular injection of 10 U bovine thyrotropin, rose to 24 and 34% at 4 and 24 hr.
Pedigree and pertinent tests of thyroid function in members of this family are shown in Fig. 3 and Table III . The family is of Polish-Jewish extraction with no known consanguinity. All members examined were euthyroid and had no goiter. The mother (R. L.) had taken thyroid hormone in the past because of tiredness and weight gain. There was however no evidence of hypothyroidism.
As of this writing, the authors have been informed that the propositus (A. L.) has achieved physical and sexual maturity without therapy.
Family N. This family was brought to our attention through the courtesy of Dr. Marvin S. Wool from the Lahey Clinic Foundation, Boston, Mass. The propositus, W. N., a 40 yr old male, presented in January 1969 with the chief complaint of nervousness and epigastric discomfort of 8 months duration, shortly after having been promoted to a higher executive position. There were no other symptoms suggestive of hyperthyroidism and physical examination was within normal limits. The thyroid gland was normal on palpation. Possible TBG abnormality was suspected on the basis of elevated PBI of 18.4 ,ug/100 ml and a normal 24 hr thyroidal ...I uptake of 11%, in a clinically euthyroid patient. The family is Caucasian, there was no history of consanguinity, and all subjects examined were clinically euthyroid and had no goiter except for N. V., the 60 yr old mother of the propositus. Goiter in N. V. was discovered on routine physical examination, 1i yr. before the initiation of this study. She was postmenopausal and was not taking estrogen-containing drugs. There were no stigmata of hyper-or hypothyroidism except for a 60 lb.
'Performed by Bio-Science Laboratories, Van Nuys, Calif.; normal range 1.6-2.4 ng/100 ml. weight loss under strict diet, over the period of 3i yr. Thyroid gland was approximately three times the normal size, firm and finely nodular.
Pedigree and pertinent data on thyroid hormone transport in serum of members of this family appear in Fig. 4 and Table IV .
RESULTS
Purification of TBG. Results from the first serum fractionation carried on Pevikon-block electrophoresis Initials and ages are given above are depicted in Fig. 5 . 89.4% of the total T4-'5I migrated as TBG in the inter-a-globulin zone, and 5.6% with the albumin. The remaining 5% of the total 'I activity was lost in the buffer tank and probably represents iodide-'I contaminant. Since in the presence of barbital buffer, T4 does not bind to TBPA (39) , no T4-l5I was recovered from the prealbumin zone. The specific activity of TBG, in the pooled two peak fractions, increased 17-fold and the recovery was 75%. BLE Further purification of a concentrate of these fractions, on Sephadex G-100 ( Fig. 6 ), resulted in an additional 6.2-fold increase in the specific activity of the three pooled fractions from the peak T4-'I recovered (fractions 10, 11, and 12). Antibodies to TBG. Only one of the two immunized rabbits produced adequate antibody titer. The ability of the antibody to bind TBG was demonstrated on both paper and agarose electrophoreses. When antiserum was incubated with normal human serum enriched with T4-10I, the activity was displaced from its usual location on TBG to the origin and y-globulin zone (Fig.   7 ). Reaction between antibody and TBG did not displace the T4 bound to TBG. As a matter of fact, the same amount of T4-"'I was associated with the antibody-TBG complex when T4-OI was added to the serum before or after incubation with the antiserum. The lack of interference of the antibodies with TU-binding to TBG suggests that the former bind to a site on the TBG molecule distinct from that responsible for T4-binding, and that the tertiary configuration of the antibody-TBG complex left access to the T4-binding site on TBG unobstructed.
Untreated rabbit antiserum was not monospecific for TBG. At least six precipitation peaks were observed on stained antigen-antibody crossed electrophoresis. However, antibodies against albumin were not a major contaminant and radioautography of the same plate produced a single peak corresponding to the location of the TBG-antibody complex. Accordingly, rabbit antiserum was adsorbed with serum from a patient with TBG deficiency provided by Dr. T. W. Avruskin. This patient was unrelated to the families reported in this communication. The adsorbed antiserum gave a single arc on immunoelectrophoresis with normal human serum. No precipitin arc was observed with TBG-deficient serum from a member of family P (Mi. P.) (Fig. 8 ).
Immunologic properties of TBG in sera from subjects with inherited TBG abnormalities. Since our antiserum 3LE Similarly, reduction in the TBG antibody titer was proportional to the TBG capacity of serum from a normal subject (D. S. R.) and that from a subject with inherited increase in TBG capacity (W. N.). Adsorbed antiserum, which in the presence of normal serum produced a single arc on immunoelectrophoresis (Fig. 8) , was used for the Ouchterlony double diffusion plate. As depicted on Fig. 9 , sera from subjects with very low, half normal, normal, and high TBG capacity produced a single precipitin line, on the protein-stained plate. TBG-deficient serum failed to produce visible precipitation. Identical results were obtained with sera from all other hemizygous patients with TBG deficiency. Although quantitative differences in Physicochemical properties of TBG in sera from subjects with inherited TBG abnormalities. The T4 association constant of TBG in serum from subjects with decreased, normal, and high TBG capacities was estimated by the competitive binding technique utilized in the TT4 assay. Similarity in the TBG association constants in these sera is indicated by the slope of the curves (Fig. 10) . The shift of the saturation curves is proportional to the maximal T4-binding capacity of TBG. Similar results were obtained using triiodothyronine as a ligand.
Finally, the rate of TBG inactivation at 60'C was not statistically different in sera from subjects with high, normal, and low TBG capacities (Fig. 11) .
Protein FIGURE 5 Purification of TBG on Pevikon-block electrophoresis (barbital buffer, pH 8.6). 10 ml of serum from a healthy pregnant female at term (TBG capacity 61 ,ug T4/100 ml), enriched with a tracer T4-'I (2 ng) was applied to the origin. Protein concentration and "II activity were measured on eluates from sections of supporting medium. Per cent of the total "'I activity recovered in the TBG and albumin zones is indicated.
concentration of the labeled hormones. It can be seen in Fig. 12 , that although estrogen treatment failed to demonstrate TR-binding in the inter-a-globulin zone of the TBG-deficient serum, binding to cortisol-binding globulin (CBG) and testosterone-binding globulin (TeBG) was increased when compared with the normal control. No obvious differences were noted in aldosterone-binding to serum, using this technique.
Effect of T4 administration. A hemizygous subject (P. R.) from family P was given T4 in incremental doses (0.1, 0.2, and 0.3 mg daily), changing the dosage every 2 wk. TBG and TBPA capacities remained unchanged. As in subjects with normal TBG capacity, stepwise suppression of thyroid gland activity was observed. During the control period thyroidal "tI uptake was 30% dropping to 14, 7, and 0.6% on the final dose of 0.3 mg of T4 daily. The TTI rose from 2.4 to 5.0 tg/100 ml. In the absence of changes in the TBG capacity, TT4 elevation was interpreted as being the result of endogenous T3 suppression.
Studies of TBG gene location on the X-chromosome. Information on genetic linkage was sought in order to help mapping the locus of TBG gene on the X-chromosome. Two X-linked genetic characters, red-green color vision, and the Xg' red-cell antigen were examined. All studied members from families A, G, L, and N had normal color vision and were Xg' positive. Results from a similar study in subjects from family P have been previously reported (5).
DISCUSSION
Of the five families with inherited TBG abnormalities studied, the TBG-deficient "family P" satisfied all criteria supporting X-linkage (5) mals by partial expression of the trait. This observation offers no proof for but is compatible with the singleactive-X hypothesis (Lyon's hypothesis) which proposes random and permanent inactivation of all Xchromosomes in excess of one in somatic cells during early fetal life (41) (42) (43) (44) . It is rationalized that this inactivation provides a mechanism of dosage compensation for X-chromosome-linked traits.
In the three families with low TBG (families A, G, and L), males were always more profoundly affected than females, permitting distinction between the affected hemizygous and heterozygous states, thus satisfying criteria (a), (b), and (g). Most importantly, all available hemizygous offspring of affected males were normal and female offspring heterozygous. Criterion (g) was not completely satisfied in family G as the affected b'. was undoubtedly responsible for overlooking a typical X-linked inheritance pattern in at least two families (13, 20) . The pedigree of "family N" with high TBG satisfied criteria (a), (b), (e), (g), and most importantly (d).
Data for (c) and (e) were unavailable. Mean TBG capacity of the heterozygous female (N. V.) was 49.6 compared with 89.2 Ag T4/100 ml in the affected male (W. N.). Assuming that the heterozygote has a cellular mosaic with respect to paternal and maternal X-chromosomes, and that random inactivation resulted in an even number of both cell types, the expected TBG capacity for N. V. should be approximately 55 og T4/100 ml, which is similar to the observed value of 49.6. Since evidence for X-linked inheritance was presented in two-thirds of families with TBG abnormalities so far described, and it has been repeatedly suggested that in the remaining one-third some families possess many features compatible with an identical mode of inheritance (3, 5, Reduced, but detectable TBG capacity in the affected hemizygotes (L) have been described in 11 families including the 3 families described in this communication. , and the pedigree fulfills all criteria for X-linkage. Consistency with Xchromosome-linked inheritance is also apparent in family H-2, with TBG capacity in the single affected male higher than any of the three affected females. In all families, there is a remarkable consistency in the degree of TBG elevation in affected males (mean TBG elevation 2.8-to 4.3-fold normal) as compared with affected females (mean TBG elevation 2.0-to 2.4-fold normal). Absolute TBG capacities reported vary over a wider range according to methodological differences.
As the most crucial criterion supporting X-linked inheritance is lack of male-to-male transmission, the progeny of all affected males was analyzed (Table X) . All sons were normal and most daughters could be identified as heterozygous. The probability that this distribution would have occurred by chance if inherited as autosomal dominant is less than 1: 2,000 for D, less than 1: 4,000 for L, and less than 1: 2,000,000 for H.
TBPA concentration was normal in our families and in others (5, 8, 10, 11, 14, 15, 20) . In only one family (L-6) TBPA levels appeared to have an inverse correlation with the TBG capacity (13) . Similarly, other serum proteins including CBG (3, 8, 16, 18) 6.7 7.1 TIME (min ) FIGURE 11 Rate of TBG inactivation at 60'C. Portions of serum from each subject were heated in a constant temperature bath, for variable periods of time, as indicated on the abscissa. The serum was then immediately cooled in an ice bath and the TBG capacity determined.
globin (3, 14) , iron-binding globulin (3, 8) , and ceruloplasmin (3) were present in normal concentrations. The turnover rate of serum albumin was normal in one of our patients with TBG deficiency (5) . CBG responds normally to the administration of estrogens or to pregnancy (3, 5, 16) . Although associated abnormalities such as hypothyroidism (3, 11) , toxic nodular goiter (18) (11) have been described, these associations are believed to be fortuitous. On the other hand, Shane, Seal, and
Jones described a family with increased TBG and high incidence of goiter (12 of the 14 affected subjects) (19) . Hereditary ectodermal dysplasia of the anhidrotic type, also often manifesting as an X-chromosome-linked disorder (49) was associated with inherited TBG elevation (17, 48) . A male presenting with this full blown syndrome had also the highest TBG capacity.
His mother and maternal grandmother with intermediary TBG capacity elevations had very thin hair and abnormalities in teeth eruption also suggestive of heterozygosity for ectodermal dysplasia. As the authors do not mention whether two additional members of this family, with high TBG, exhibited stigmata of ectodermal dysplasia, the possibility of proximity for the two loci on the X-chromosome is uncertain. Localization of the TBG locus on the X-chromosome was sought from information of genetic studies using two known X-linked traits namely color vision, and the Xga red-cell antigen. None of the subjects tested had red-green color blindness and all were Xg' positive except for three members from family P. Although data from Xga-typing in this family were useful in the identification of the maternal origin of the single X in a patient with Turner's syndrome, no conclusions can be drawn as to its proximity to the TBG locus (5) . Similar attempts of linkage tests in families with TBG de-ficiency (2, 7), one with low (11), and one with high TBG (16) have failed. More extensive study of the Xge red-cell antigen in a family with high TBG indicates that it is very unlikely that the two loci are closely linked (18) .
The mechanisms for production of these inherited TBG abnormalities remain obscure. Hypotheses such as production of an abnormal protein with altered binding affinity and/or capacity (4, 5, 11, 12, 15, 16, 18, 20) , presence of an abnormal substance interfering with TR-binding to TBG (5) or absence of normally present extraneous inhibitor of T&-protein interaction (20) , abnormality in the mechanism controlling TBG synthesis and possible degradation resulting in quantitative variations in TBG concentration (5, 12, 15, 18, 20) , and presence of two types of TBG controlled by different genes (5), have been considered. Based on the model of genetic control of protein synthesis in bacteria, structural gene mutations (4, 5, 11, 16, 18, 20) , mutations at the control sites (repressor) or operator (5, 16, 18) , and structural gene duplication resulting in double quantity of dose of a gene (16, 18) have been also considered. Unfortunately, evidence for any particular mechanism is lacking and is at best, only partial.
Serum of all hemizygous members from our family with TBG deficiency ("family P") and that of another affected male from an unrelated family lacked immunoreactive TBG when assayed by two different laboratories, utilizing two different antisera for the Ouchterlony technique, radioimmunoassay and titration by antibody adsorption. Recently absence of immunoreactive TBG was reported in two affected males from family D-1 (33) . The same authors question the validity of earlier results which suggested presence of a defective TBG in these patients (40) . TBG was also quantitated by two electrophoretic methods, a method utilizing resin as competitor of TR-binding and by radioimmunoassay giving similar results for all patients covering the spectrum of TBG abnormalities.°TBGs in both hemizygous and heterozygous members of families with low or high TBG, as well as heterozygotes from the family with TBG deficiency, have similar affinity for either To or Ts and do not differ in their behavior to heat inactivation. Other authors have shown no differences in the electrophoretic mobility on polyacrylamide (3, 11, 12) , cellulose acetate (7), and 2 dimension paper-starch (20) electrophoreses using a variety of buffer systems. Similarity in the shape of the TBG stabilization curve of normal sera and sera from patients with inherited TBG elevation has been demonstrated (15 ing with Tt-binding to TBG. It is therefore apparent that data so far available, fail to demonstrate the presence of structural alterations of TBG in patients covering the entire spectrum of inherited TBG abnormalities. The effect of estrogen administration on the TBG capacity of both hemizygous and heterozygous subjects with different inherited TBG abnormalities is listed in Table XI . In all patients with TBG deficiency, administration of estrogens failed to result in detectable T4-binding to the TBG zone. However, heterozygotes responded with elevation in the TBG capacity. Other estrogen-dependent serum proteins responded normally. In one patient with TBG deficiency (Mi. P.), evidence for increase in the CBG and TeBG capacity was obtained by semiquantitative analysis on agarose electrophoresis (Fig. 12) . Estrogen had no apparent effect on aldosterone-binding to serum proteins. Estrogens had a less uniform effect on the T4-binding capacity of TBG in subjects from families with low and high TBG. TBG capacity remained unchanged in one (11) , but increased in another (14) hemizygous affected subject with low TBG. Similarly, evidence for increase in TBG capacity was not obtained in all patients with high TBG. Thus conclusions on the genetic mechanism of inherited TBG abnormalities based on such data (16) (C. A.), a 2-to 2i-fold elevation in the TBG capacity could be achieved after treatment with estrogens for 3-4 months. Serial determinations of the TBG capacity after discontinuation of therapy revealed a slow decline with return to pretreatment values after 6-8 wk, which is similar to that observed in normal controls (33) . It is therefore fair to conclude that the abnormal TBG concentration in serum from these patients is not due to altered rate of TBG degradation. Examples of abnormalities in the enzymatic activity and in rates of synthesis of enzymes due to structural gene mutations have been described in man. Deficiency with discrepancy between the quantitation of the protein enzyme by immunologic and enzymatic assays in the case of the "silent gene" for pseudocholinesterase (51) , and increase in both enzymatic and immunologic activities in the case of both Hektoen variant of glucose-6-phosphate dehydrogenase (G6PD) (52) and pseudocholinesterase-E Cynthiana (53) have been noted.
A single amino acid substitution in the G6PD Hektoen was demonstrated (54) , and although no differences were found by comparing the immunologic and enzymatic activities or by studies of the kinetics of termostability, structural abnormality was suspected on the basis of differences in electrophoretic mobility (52, 54) . Similarly, E Cynthiana could be distinguished from the common enzyme both electrophoretically and by the association of the subunits.
No electrophoretic abnormalities of TBG could be demonstrated using four different supporting media and five buffers. Furtnermore, the properties of the TBG antiserum used in our study is unique in that biological activity (T.-binding to TBG) was not inhibited after the formation of the antigen-antibody complex. Thus, a fundamental difference exists between our studies and studies of G6PD and pseudocholinesterase variants in which addition of antisera produced proportional loss of the biologic activity. In this instance, quantitation of Table VII. tary axis by Ts suppression (7, 15, 50) , and TSH stimulation tests (3) . No abnormalities could be detected.
Similarly, the BMR (5, 7, 8, 20, 39) , cholesterol (3, 5, 7, 13, 16, 17, 20, 39, 50, 55, 56) , and thyroidal 'I uptake (3, 7, 10, 15-17, 20, 39, 50, 55-57) were within normal limits. No evidence for thyroid autoimmunity could be obtained from measurement of circulation thyroglobulin antibodies (5, 11) . In this study and others (1, 5, 15) , no adrenal or pituitary abnormalities could be detected. The clinical impression of euthyroidism in these patients is supported by the presence of a normal level of FT. (5, 14, 16, 17) and normal daily degradation of T4 (Table XII) . The latter is achieved at the expense of an altered turnover rate compensating Inherited Thyroxine-Binding Globulin Abnormalities in Man for the wide variation in the extrathyroidal thyroxine pool associated with both high and low TBG capacities. When estrogens or pregnancy (3, 7) give rise to detectable changes of T4-binding capacity to TBG, the absolute values attained are different than those obtained in normal subjects. There is no indication, however, that pregnancy and fetal development are affected by abnormalities in either maternal or fetal TBG capacity. Finally, the dose of exogenous thyroid hormone required for substitution and thyroid gland suppression is not different from that normally used in patients with normal TBG. TBG abnormality seems to be an isolated and specific defect of thyroid hormone transport in blood. Each family presents a characteristic pattern. From our studies and those of others (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) , we suggest that all TBG abnormalities in man so far described are probably X-chromosome-linked and manifested by quantitative variations in the serum concentration of an apparently structurally unaltered TBG. Mutations at a single locus controlling TBG synthesis could then explain the entire spectrum of genetic TBG abnormalities in man.
Addendum: Since the submission of this paper, complete data related to family H-6 (19) 
